Chembio Diagnostics (CEMI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2021 | 06-2021 | 03-2021 | 12-2020 | 09-2020 | |
| Sales | 12,058 | 6,462 | 8,724 | 10,227 | 10,273 |
| Cost of Goods | 7,903 | 4,040 | 3,548 | 6,362 | 7,468 |
| Gross Profit | 4,156 | 2,422 | 5,176 | 3,865 | 2,805 |
| Operating Expenses | 10,689 | 10,799 | 9,580 | 10,772 | 8,180 |
| Operating Income | -5,631 | -8,337 | -3,856 | -6,545 | -4,908 |
| Interest Expense | 735 | 727 | 713 | 732 | 736 |
| Pre-tax Income | -6,366 | -9,065 | -4,568 | -7,276 | -5,644 |
| Income Tax | 0 | 0 | -68 | -137 | -105 |
| Net Income Continuous | -6,366 | -9,065 | -4,500 | -7,139 | -5,539 |
| Net Income | $-6,366 | $-9,064 | $-4,500 | $-7,139 | $-5,539 |
| EPS Basic Total Ops | -0.24 | -0.45 | -0.22 | -0.35 | -0.28 |
| EPS Basic Continuous Ops | -0.24 | -0.45 | -0.22 | -0.36 | -0.28 |
| EPS Diluted Total Ops | -0.24 | -0.45 | -0.22 | -0.35 | -0.28 |
| EPS Diluted Continuous Ops | -0.24 | -0.45 | -0.22 | -0.36 | -0.28 |
| EPS Diluted Before Non-Recurring Items | -0.23 | -0.35 | N/A | N/A | N/A |
| EBITDA(a) | $-4,835 | $-7,633 | $-3,168 | $-5,905 | $-4,292 |